L1CAM

L1 cell adhesion molecule, the group of CD molecules|Ig-like cell adhesion molecule family|Fibronectin type III domain containing|I-set domain containing

Basic information

Region (hg38): X:153861514-153886173

Previous symbols: [ "HSAS1", "SPG1", "HSAS", "MASA", "MIC5", "S10" ]

Links

ENSG00000198910NCBI:3897OMIM:308840HGNC:6470Uniprot:P32004AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • MASA syndrome (Definitive), mode of inheritance: XLR
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (Definitive), mode of inheritance: XLR
  • X-linked complicated corpus callosum dysgenesis (Definitive), mode of inheritance: XLR
  • X-linked complicated corpus callosum dysgenesis (Strong), mode of inheritance: XL
  • MASA syndrome (Strong), mode of inheritance: XL
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (Strong), mode of inheritance: XL
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (Supportive), mode of inheritance: XL
  • MASA syndrome (Supportive), mode of inheritance: XL
  • X-linked complicated corpus callosum dysgenesis (Supportive), mode of inheritance: XL
  • X-linked complicated spastic paraplegia type 1 (Supportive), mode of inheritance: XL
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (Definitive), mode of inheritance: XL
  • X-linked complicated corpus callosum dysgenesis (Strong), mode of inheritance: XL
  • L1 syndrome (Definitive), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hydrocephalus due to congenital stenosis of aqueduct of Sylvius; Mental retardation, aphasia, shuffling gait, and adducted thumbs (MASA) syndrome; CRASH syndrome; Corpus callosum, partial agenesis of; Spastic paraplegia-1XLGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingGastrointestinal; Musculoskeletal; Neurologic4855169; 7070456; 6702900; 2737668; 2277384; 1870106; 1303258; 7920659; 8062435; 7920660; 8556302; 7562969; 9279760; 15368500; 16650080; 21271669; 21644943; 21839187; 21961551; 22222883; 22344793; 22354677
Individuals may be at risk for findings including Hirschsprung disease as well as hydrocephalus

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the L1CAM gene.

  • not provided (44 variants)
  • Spastic paraplegia (39 variants)
  • X-linked hydrocephalus syndrome (11 variants)
  • L1 syndrome (8 variants)
  • Hydrocephalus due to aqueductal stenosis (4 variants)
  • L1CAM-related disorder (3 variants)
  • MASA syndrome (3 variants)
  • L1CAM-related disorders (2 variants)
  • Inborn genetic diseases (2 variants)
  • X-linked complicated corpus callosum dysgenesis (1 variants)
  • Global developmental delay (1 variants)
  • Hydrocephalus, X-linked, with congenital idiopathic intestinal pseudoobstruction (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the L1CAM gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
3
clinvar
238
clinvar
67
clinvar
309
missense
10
clinvar
17
clinvar
193
clinvar
91
clinvar
59
clinvar
370
nonsense
32
clinvar
7
clinvar
39
start loss
2
clinvar
2
frameshift
23
clinvar
13
clinvar
36
inframe indel
7
clinvar
7
splice donor/acceptor (+/-2bp)
14
clinvar
18
clinvar
1
clinvar
1
clinvar
34
splice region
2
7
18
50
9
86
non coding
1
clinvar
1
clinvar
1
clinvar
174
clinvar
68
clinvar
245
Total 80 59 205 504 194

Highest pathogenic variant AF is 0.00000894

Variants in L1CAM

This is a list of pathogenic ClinVar variants found in the L1CAM region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-153862280-G-A Hereditary spastic paraplegia Benign/Likely benign (Jan 03, 2017)1344425
X-153862460-C-G Likely benign (Oct 09, 2018)1219357
X-153862504-A-G Benign (Mar 03, 2015)1252419
X-153862663-C-A Inborn genetic diseases Uncertain significance (Sep 30, 2018)985218
X-153862663-C-G Likely pathogenic (Dec 06, 2017)449970
X-153862663-C-T Spastic paraplegia Likely benign (Jun 02, 2023)1110626
X-153862664-T-A Spastic paraplegia Uncertain significance (Jan 19, 2024)2708192
X-153862667-T-C Spastic paraplegia Uncertain significance (Sep 01, 2021)458215
X-153862669-T-C Spastic paraplegia Benign (Jul 11, 2023)2899524
X-153862671-G-A Spastic paraplegia Likely benign (Apr 02, 2023)2851586
X-153862673-G-A Spastic paraplegia Benign (Oct 26, 2023)2911131
X-153862674-C-T Spastic paraplegia • L1CAM-related disorder Benign (Dec 14, 2023)2995235
X-153862677-C-T Spastic paraplegia Benign (Nov 14, 2023)2728874
X-153862678-G-A Spastic paraplegia Likely benign (Dec 27, 2023)2961710
X-153862682-G-T MASA syndrome Uncertain significance (Feb 02, 2022)1698960
X-153862683-G-A X-linked complicated corpus callosum dysgenesis Uncertain significance (Apr 11, 2019)1030783
X-153862685-T-G Spastic paraplegia Uncertain significance (Sep 22, 2022)1718234
X-153862690-G-T Spastic paraplegia Benign (Jan 14, 2024)2725540
X-153862693-G-A Spastic paraplegia Likely benign (Dec 21, 2022)2822832
X-153862698-T-C Spastic paraplegia Benign (Jul 16, 2023)2730309
X-153862702-C-T Spastic paraplegia Benign/Likely benign (Jan 25, 2024)698291
X-153862703-C-T Spastic paraplegia Uncertain significance (Dec 06, 2022)1513685
X-153862716-T-C Spastic paraplegia Uncertain significance (May 08, 2022)2135330
X-153862726-C-T Inborn genetic diseases • Spastic paraplegia Likely benign (Nov 07, 2023)589105
X-153862727-G-A Spastic paraplegia • Inborn genetic diseases Benign/Likely benign (Jan 19, 2024)1050405

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
L1CAMprotein_codingprotein_codingENST00000370060 2847709
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.005.37e-7125737111257390.00000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.843735620.6630.00005008251
Missense in Polyphen106240.90.440023609
Synonymous-0.6592572441.050.00002292479
Loss of Function6.22249.00.04080.00000372734

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002440.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Neural cell adhesion molecule involved in the dynamics of cell adhesion and in the generation of transmembrane signals at tyrosine kinase receptors. During brain development, critical in multiple processes, including neuronal migration, axonal growth and fasciculation, and synaptogenesis. In the mature brain, plays a role in the dynamics of neuronal structure and function, including synaptic plasticity. {ECO:0000269|PubMed:20621658, ECO:0000305}.;
Disease
DISEASE: Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000]: Hydrocephalus is a condition in which abnormal accumulation of cerebrospinal fluid in the brain causes increased intracranial pressure inside the skull. This is usually due to blockage of cerebrospinal fluid outflow in the brain ventricles or in the subarachnoid space at the base of the brain. In children is typically characterized by enlargement of the head, prominence of the forehead, brain atrophy, mental deterioration, and convulsions. In adults the syndrome includes incontinence, imbalance, and dementia. HSAS is characterized by mental retardation and enlarged brain ventricles. {ECO:0000269|PubMed:10797421, ECO:0000269|PubMed:11857550, ECO:0000269|PubMed:12435569, ECO:0000269|PubMed:12514225, ECO:0000269|PubMed:19846429, ECO:0000269|PubMed:20621658, ECO:0000269|PubMed:22344793, ECO:0000269|PubMed:22973895, ECO:0000269|PubMed:24155914, ECO:0000269|PubMed:7562969, ECO:0000269|PubMed:7762552, ECO:0000269|PubMed:7881431, ECO:0000269|PubMed:7920659, ECO:0000269|PubMed:8401576, ECO:0000269|PubMed:8556302, ECO:0000269|PubMed:8929944, ECO:0000269|PubMed:9118141, ECO:0000269|PubMed:9195224, ECO:0000269|PubMed:9268105, ECO:0000269|PubMed:9521424, ECO:0000269|PubMed:9744477, ECO:0000269|PubMed:9832035}. Note=The disease is caused by mutations affecting the gene represented in this entry. L1CAM mutations have also been found in few patients affected by hydrocephalus with Hirschsprung disease, suggesting a role of this gene acting either in a direct or indirect way in the pathogenesis of Hirschsprung disease (PubMed:22344793). {ECO:0000269|PubMed:22344793}.; DISEASE: Mental retardation, aphasia, shuffling gait, and adducted thumbs syndrome (MASA) [MIM:303350]: An X-linked recessive syndrome with a highly variable clinical spectrum. Main clinical features include spasticity and hyperreflexia of lower limbs, shuffling gait, mental retardation, aphasia and adducted thumbs. The features of spasticity have been referred to as complicated spastic paraplegia type 1 (SPG1). Some patients manifest corpus callosum hypoplasia and hydrocephalus. Inter- and intrafamilial variability is very wide, such that patients with hydrocephalus, MASA, SPG1, and agenesis of corpus callosum can be present within the same family. {ECO:0000269|PubMed:10797421, ECO:0000269|PubMed:10805190, ECO:0000269|PubMed:11857550, ECO:0000269|PubMed:16816908, ECO:0000269|PubMed:19846429, ECO:0000269|PubMed:22344793, ECO:0000269|PubMed:22973895, ECO:0000269|PubMed:24155914, ECO:0000269|PubMed:26891472, ECO:0000269|PubMed:7562969, ECO:0000269|PubMed:7762552, ECO:0000269|PubMed:7881431, ECO:0000269|PubMed:7920659, ECO:0000269|PubMed:7920660, ECO:0000269|PubMed:8556302, ECO:0000269|PubMed:9268105, ECO:0000269|PubMed:9300653, ECO:0000269|PubMed:9452110, ECO:0000269|PubMed:9521424, ECO:0000269|PubMed:9744477, ECO:0000269|PubMed:9832035}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in L1CAM may contribute to Hirschsprung disease by modifying the effects of Hirschsprung disease- associated genes to cause intestinal aganglionosis. {ECO:0000269|PubMed:11857550}.; DISEASE: Agenesis of the corpus callosum, X-linked, partial (ACCPX) [MIM:304100]: A syndrome characterized by partial corpus callosum agenesis, hypoplasia of inferior vermis and cerebellum, mental retardation, seizures and spasticity. Other features include microcephaly, unusual facies, and Hirschsprung disease in some patients. {ECO:0000269|PubMed:16650080}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in L1CAM are associated with a wide phenotypic spectrum which varies from severe hydrocephalus and prenatal death (HSAS) to a milder phenotype (MASA). These variations may even occur within the same family. Due to the overlap of phenotypes between HSAS and MASA, many authors use the general concept of L1 syndrome which covers both ends of the spectrum. {ECO:0000269|PubMed:19846429, ECO:0000269|PubMed:22222883, ECO:0000269|PubMed:26891472}.;
Pathway
Cell adhesion molecules (CAMs) - Homo sapiens (human);Axon guidance - Homo sapiens (human);Developmental Biology;Recycling pathway of L1;Beta3 integrin cell surface interactions;Interaction between L1 and Ankyrins;Cell surface interactions at the vascular wall;Hemostasis;Signal transduction by L1;L1CAM interactions;Axon guidance;Basigin interactions (Consensus)

Intolerance Scores

loftool
0.0181
rvis_EVS
-1.3
rvis_percentile_EVS
4.92

Haploinsufficiency Scores

pHI
0.367
hipred
Y
hipred_score
0.631
ghis
0.575

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.843

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
L1cam
Phenotype
growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; craniofacial phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
l1cama
Affected structure
medial longitudinal fasciculus
Phenotype tag
abnormal
Phenotype quality
defasciculated

Gene ontology

Biological process
chemotaxis;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;cell-matrix adhesion;nervous system development;axon guidance;cell migration;neuron projection development;positive regulation of axon extension;synapse organization;leukocyte migration;axon development
Cellular component
plasma membrane;focal adhesion;cell surface;integral component of membrane;axon;dendrite;neuronal cell body;axonal growth cone;collagen-containing extracellular matrix
Molecular function
protein binding;axon guidance receptor activity;protein domain specific binding